[5] Several biological mechanisms have been proposed in preclinical research that suggest plausible links between GLP-1 signalling and brain health: Neuroprotection : In laboratory and animal studies, GLP-1 receptor activation may protect neurons from oxidative stress and inflammation, both of which contribute to neurodegeneration [5] Neurogenesis : Animal studies suggest GLP-1 may promote the growth of new neurons in the hippocampus, a region essential for memory Reduction of amyloid plaques : Preclinical research indicates potential effects on beta-amyloid accumulation, a hallmark of Alzheimer's disease [5] Anti-inflammatory effects : Chronic neuroinflammation is implicated in various forms of dementia The connection between metabolic health and cognitive function provides additional rationale for investigating GLP-1 agents in dementia
It significantly improves the odds of better skin quality compared to weight loss without any tissue support
6 Limitations and the Honest Bottom Line Pulling the threads together, the limitations bearing on the title question are specific and, importantly, they reinforce one another rather than sitting in isolation
Mechanisms governing metastatic dormancy and reactivation
extended/indefinite therapy for unprovoked DVT, cancer-associated DVT, or recurrent DVT